alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Clinical and Basic Science Study Section.                    

*Date:*                         June 23-24, 2022.                    

*Time:*                         10:30 a.m. to 6:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Heart, Lung, and Blood Institute, RKL1, 6705 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Rajiv Kumar, Ph.D., Chief, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6705 Rockledge Drive, Bethesda, MD 20892, (301) 827-4612,                         *rajiv.kumar@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: May 4, 2022.

David W. Freeman,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-09963 Filed 5-9-22; 8:45 am]

BILLING CODE 4140-01-P
[Federal Register Volume 87, Number 89 (Monday, May 9, 2022)]
[Notices]
[Page 27669]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-09858]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-94841; File No. SR-MEMX-2022-02]


Self-Regulatory Organizations; MEMX LLC; Notice of Withdrawal of 
a Proposed Rule Change To Amend the Exchange's Fee Schedule to Adopt 
Connectivity Fees

May 3, 2022.
    On March 1, 2022, MEMX LLC (``MEMX'') filed with the Securities and 
Exchange Commission (``Commission''), pursuant to Section 19(b)(1) of 
the Securities Exchange Act of 1934 \1\ and Rule 19b-4 thereunder,\2\ a 
proposed rule change to amend its Fee Schedule to adopt Connectivity 
Fees. The proposed rule change was immediately effective upon filing 
with the Commission pursuant to Section 19(b)(3)(A) of the Act.\3\ The 
proposed rule change was published for comment in the Federal Register 
on March 21, 2022.\4\ On April 29, 2022, MEMX withdrew the proposed 
rule change (SR-MEMX-2022-02).\5\
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A). A proposed rule change may take 
effect upon filing with the Commission if it is designated by the 
exchange as ``establishing or changing a due, fee, or other charge 
imposed by the self-regulatory organization on any person, whether 
or not the person is a member of the self-regulatory organization.'' 
15 U.S.C. 78s(b)(3)(A)(ii).
    \4\ See Securities Exchange Act Release No. 94419 (March 15, 
2022), 87 FR 16046.
    \5\ See Letter from Anders Franzon, General Counsel, MEMX, to 
Vanessa Countryman, Secretary, Commission, dated April 29, 2022.

    For the Commission, by the Division of Trading and Markets, 
pursuant to delegated authority.\6\
---------------------------------------------------------------------------

    \6\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2022-09858 Filed 5-6-22; 8:45 am]
BILLING CODE 8011-01-P
Joshua KELLY, petitioner, v. UNITED STATES.

No. 17-9416.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
**EXHIBIT 23.1**

 

 

**CONSENT OF INDEPENDENT ACCOUNTANTS**

 

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos.333-100228, 333-86436, 333-65986, 333-51408, 333-45634, and 333-89653) and Form S-3 (No. 333-87076) of LookSmart, Ltd. of our report dated January 23, 2003, except as to Note 19, which is as of March 14, 2003, relating to the financial statementsand financial statement schedule, which appears in this Form 10-K. 

 

/s/    PRICEWATERHOUSECOOPERS LLP 

 

San Francisco, California 

March 14, 2003
Bekim FISEKU, petitioner, v. UNITED STATES.

No. 18-8631.

Supreme Court of the United States

April 29, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
EXHIBIT 31.1
 
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
 PURSUANT TO SECTION 302
 OF THE SARBANES-OXLEY ACT OF 2002
   I, Stanley Shuster, certify that:
 1.
I have reviewed this Quarterly Report on Form 10-QSB of Grand Havana Enterprises, Inc.;2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
  a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;b)
Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; andc)
Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
   5.
I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
  a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
 b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
  Date: February 9, 2005
By:
/s/ Stanley ShusterName: Stanley ShusterIts: Chief Executive Officer and Chief Financial Officer
Norman L. HUNTER, petitioner, v. UNITED STATES.

No. 18-5062.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER ON MOTION

Case number: 01-12-00847-CV

Style: Northern & Western Insurance Company Ltd., Appellant 

v. Sentinel Investment Group, LLC, Appellee

Type of motion: Motion for rehearing filed November 15, 2013

Party filing motion: Appellant

It is ordered that the motion for rehearing is denied. 

Judge’s signature: /s/ Jane Bland

Acting for the Court

Panel consists of Chief Justice Radack and Justices Bland and Huddle. 

Date: February 13, 2014.
<TABLE> <S> <C>

<ARTICLE>             5
<MULTIPLIER>          1000



<S>                                 <C>
<PERIOD-TYPE>                               3-MOS
<FISCAL-YEAR-END>                           Dec-31-2000
<PERIOD-START>                              Jan-01-2000
<PERIOD-END>                                Mar-31-2000
<CASH>                                      1690
<SECURITIES>                                1216
<RECEIVABLES>                               3833
<ALLOWANCES>                                552
<INVENTORY>                                 0
<CURRENT-ASSETS>                            6434
<PP&E>                                      2449
<DEPRECIATION>                              1063
<TOTAL-ASSETS>                              7882
<CURRENT-LIABILITIES>                       2293
<BONDS>                                     0
<PREFERRED-MANDATORY>                       0
<PREFERRED>                                 0
<COMMON>                                    1
<OTHER-SE>                                  5446
<TOTAL-LIABILITY-AND-EQUITY>                7882
<SALES>                                     3567
<TOTAL-REVENUES>                            3567
<CGS>                                       1197
<TOTAL-COSTS>                               1197
<OTHER-EXPENSES>                            1858
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                          5
<INCOME-PRETAX>                             507
<INCOME-TAX>                                203
<INCOME-CONTINUING>                         304
<DISCONTINUED>                              0
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                                304
<EPS-BASIC>                               .06
<EPS-DILUTED>                               .06





</TABLE>
<PAGE>

                                                                    EXHIBIT 13.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

        In connection with the Annual Report of Delta Galil Industries Ltd. (the
"Company") on Form 20-F for the period ending December 31, 2004, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned hereby certifies that to the best of my knowledge:

        1.      The Report fully complies with the requirements of Section 13(a)
of the Securities Exchange Act of 1934; and

        2.      The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Date: June 27, 2005

                      /s/ Arnon Tiberg
                      -------------------
                      Name:  Arnon Tiberg
                      Title: Chief Executive Officer
Gregory Alan KOKAL, petitioner, v. FLORIDA.

No. 17-9536.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Supreme Court of Florida denied.
Ramon VASQUEZ, petitioner, v. CITY OF READING, PENNSYLVANIA, et al.

No. 18-5032.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Supreme Court of Pennsylvania, Middle District denied.
<PAGE>   1
<TABLE>
<CAPTION>
                                                                                                             EXHIBIT 11.1

                                           IPC HOLDINGS, LTD. AND SUBSIDIARIES
                             RECONCILIATION OF BASIC AND DILUTED NET INCOME PER COMMON SHARE

                     (Expressed in thousands of United States dollars, except for per share amounts)
-------------------------------------------------------------------------------------------------------------------------
A reconciliation of basic and diluted earnings per share ("EPS") is given in the
following table:

                                                                                                                Amount per
Three months ended September 30, 2000                                        Income             Shares            Share
                                                                             ------             ------          ----------
<S>                                                                          <C>              <C>               <C>
Basic EPS                                                                    $ 15,029         25,033,932            $0.60
Effect of Dilutive Options                                                                       603,746
Diluted EPS                                                                  $ 15,029         25,637,678            $0.59

Three months ended September 30, 1999

Basic EPS                                                                     $ 7,797         25,033,932            $0.31
Effect of Dilutive Options                                                                     1,017,164
Diluted EPS                                                                   $ 7,797         26,051,096            $0.30
-------------------------------------------------------------------------------------------------------------------------
Nine months ended September 30, 2000

Basic EPS                                                                    $ 28,316         25,033,932            $1.13
Effect of Dilutive Options                                                                       261,170
Diluted EPS                                                                  $ 28,316         25,295,102            $1.12

Nine months ended September 30, 1999

Basic EPS                                                                    $ 25,926         25,033,932            $1.04
Effect of Dilutive Options                                                                     1,037,404
Diluted EPS                                                                  $ 25,926         26,071,336            $0.99
-------------------------------------------------------------------------------------------------------------------------
</TABLE>

                                       14
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 130 Engrossed in House (EH)]

  1st Session

                               H. R. 130

_______________________________________________________________________

                                 AN ACT

 To designate the United States courthouse located at 40 Centre Street 
    in New York, New York, as the ``Thurgood Marshall United States 
                             Courthouse''.
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
106th CONGRESS
  1st Session
                                H. R. 130

_______________________________________________________________________

                                 AN ACT

 
 To designate the United States courthouse located at 40 Centre Street 
    in New York, New York, as the ``Thurgood Marshall United States 
                             Courthouse''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION.

    The United States courthouse located at 40 Centre Street in New 
York, New York, shall be known and designated as the ``Thurgood 
Marshall United States Courthouse''.

SEC. 2. REFERENCES.

    Any references in a law, map, regulation, document, paper, or other 
record of the United States to the United States courthouse referred to 
in section 1 shall be deemed to be a reference to the ``Thurgood 
Marshall United States Courthouse''.

            Passed the House of Representatives March 23, 1999.

            Attest:

                                                                 Clerk.
```
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of NB&T Financial Group, Inc. (the Company), on Form 10-Q for the period ended June 30, 2005, dated the date of
this Certification (the Report), I, Timothy L. Smith, the President and the Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



1. The Report complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and



2. The information contained in the
Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                      |  |                                      
|--------------------- |  | -------------------------------------
|Date: August 11, 2005 |  | /s/ Timothy L. Smith                 
|                      |  | Timothy L. Smith                     
|                      |  | President and Chief Executive Officer



23
Barbara Ann THOMAS, et vir, petitioners, v. J.J. WILLIAMS.

No. 17-1641.

Supreme Court of the United States

Feb. 19, 2019.

Petition for rehearing denied.
[Federal Register Volume 87, Number 85 (Tuesday, May 3, 2022)]
[Notices]
[Page 26219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-09444]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, National Institute of Mental Health.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(6), Title 
5 U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Mental Health, including consideration of personnel 
qualifications and performance, and the competence of individual 
investigators, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, National 
Institute of Mental Health.
    Date: June 1-3, 2022.
    Time: June 1, 2022, 12:30 p.m. to 5:10 p.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Claude D. Pepper Building, 
31 Center Drive, Bethesda, MD 20892.
    Time: June 2, 2022, 11:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Claude D. Pepper Building, 
31 Center Drive, Bethesda, MD 20892.
    Time: June 3, 2022, 11:00 a.m. to 3:20 p.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Claude D. Pepper Building, 
31 Center Drive, Bethesda, MD 20892.
    Contact Person: Jennifer E. Mehren, Ph.D., Scientific Advisor, 
Division of Intramural Research Programs, National Institute of 
Mental Health, NIH, 35A Convent Drive, Room GE 412, Bethesda, MD 
20892-3747, 301-496-3501, <a href="/cdn-cgi/l/email-protection#d2bfb7baa0b7bcb892bfb3bbbefcbcbbbafcb5bda4"><span class="__cf_email__" data-cfemail="9df0f8f5eff8f3f7ddf0fcf4f1b3f3f4f5b3faf2eb">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental 
Health Research Grants, National Institutes of Health, HHS)

    Dated: April 28, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-09444 Filed 5-2-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>